Bacterial lectin BambL acts as a B cell superantigen.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 23 12 2020
accepted: 21 10 2021
revised: 03 10 2021
pubmed: 4 11 2021
medline: 15 12 2021
entrez: 3 11 2021
Statut: ppublish

Résumé

B cell superantigens crosslink conserved domains of B cell receptors (BCRs) and cause dysregulated, polyclonal B cell activation irrespective of normal BCR-antigen complementarity. The cells typically succumb to activation-induced cell death, which can impede the adaptive immune response and favor infection. In the present study, we demonstrate that the fucose-binding lectin of Burkholderia ambifaria, BambL, bears functional resemblance to B cell superantigens. By engaging surface glycans, the bacterial lectin activated human peripheral blood B cells, which manifested in the surface expression of CD69, CD54 and CD86 but became increasingly cytotoxic at higher concentrations. The effects were sensitive to BCR pathway inhibitors and excess fucose, which corroborates a glycan-driven mode of action. Interactome analyses in a model cell line suggest BambL binds directly to glycans of the BCR and regulatory coreceptors. In vitro, BambL triggered BCR signaling and induced CD19 internalization and degradation. Owing to the lectin's six binding sites, we propose a BCR activation model in which BambL functions as a clustering hub for receptor glycans, modulates normal BCR regulation, and induces cell death through exhaustive activation.

Identifiants

pubmed: 34731252
doi: 10.1007/s00018-021-04009-z
pii: 10.1007/s00018-021-04009-z
pmc: PMC8629787
doi:

Substances chimiques

Bacterial Proteins 0
Lectins 0
Polysaccharides 0
Receptors, Antigen, B-Cell 0
Superantigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8165-8186

Subventions

Organisme : Max-Planck-Gesellschaft
ID : IMPRS-MCB
Organisme : Deutsche Forschungsgemeinschaft
ID : RTG-2202
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC-294
Organisme : Deutsche Forschungsgemeinschaft
ID : GSC-4
Organisme : Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
ID : Az: 33 7532.20

Informations de copyright

© 2021. The Author(s).

Références

Anal Biochem. 2003 Mar 15;314(2):266-80
pubmed: 12654314
Nature. 2007 Nov 29;450(7170):670-5
pubmed: 18046403
J Biol Chem. 2002 Mar 8;277(10):7766-75
pubmed: 11726649
J Immunol. 1982 Sep;129(3):1336-42
pubmed: 6286763
J Immunol. 1996 Apr 15;156(8):2743-53
pubmed: 8609392
Blood. 2004 Feb 15;103(4):1425-32
pubmed: 14563648
Am J Infect Control. 1996 Oct;24(5):389-95
pubmed: 8902114
Nat Rev Immunol. 2010 Nov;10(11):767-77
pubmed: 20935671
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1106-18
pubmed: 26862060
Biol Direct. 2020 Mar 4;15(1):6
pubmed: 32131884
Cancer Immunol Immunother. 2008 Sep;57(9):1381-90
pubmed: 18297282
Springer Semin Immunopathol. 2005 Mar;26(4):463-84
pubmed: 15633015
Biochim Biophys Acta. 2013 Aug;1828(8):1840-5
pubmed: 23528203
Curr Opin Struct Biol. 2020 Jun;62:39-47
pubmed: 31841833
Mol Cell Proteomics. 2018 Apr;17(4):565-579
pubmed: 29326176
J Immunol. 2007 Mar 1;178(5):2636-40
pubmed: 17312102
Sci Rep. 2016 Oct 31;6:36298
pubmed: 27796362
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):
pubmed: 33563755
J Biol Chem. 2005 Aug 12;280(32):29080-7
pubmed: 15955802
mSphere. 2019 Mar 27;4(2):
pubmed: 30918063
J Clin Microbiol. 2005 Jun;43(6):2926-8
pubmed: 15956421
Life Sci Alliance. 2019 Nov 15;2(6):
pubmed: 31732693
Nat Immunol. 2019 Nov;20(11):1425-1434
pubmed: 31611702
J Exp Med. 1995 Apr 1;181(4):1581-6
pubmed: 7535343
Biochim Biophys Acta. 2015 Apr;1853(4):858-71
pubmed: 25450969
Infect Immun. 2004 Sep;72(9):5412-8
pubmed: 15322039
mBio. 2020 Mar 10;11(2):
pubmed: 32156827
J Immunol. 1996 May 15;156(10):3608-20
pubmed: 8621894
Front Immunol. 2019 Apr 04;10:699
pubmed: 31019513
Immunol Res. 2000;22(2-3):281-98
pubmed: 11339363
Nat Commun. 2018 Aug 17;9(1):3287
pubmed: 30120234
J Immunol. 1989 Apr 15;142(8):2943-8
pubmed: 2703712
Elife. 2014 Jun 24;3:e02069
pubmed: 24963139
Med Microbiol Immunol. 1996 Feb;184(4):185-93
pubmed: 8811651
J Biol Chem. 1993 Nov 15;268(32):24145-8
pubmed: 8226961
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Elife. 2020 Oct 07;9:
pubmed: 33025904
Front Immunol. 2018 Sep 28;9:2235
pubmed: 30323814
J Immunol. 1982 Aug;129(2):596-602
pubmed: 6979579
J Natl Cancer Inst. 1980 Mar;64(3):477-83
pubmed: 6243722
Structure. 2001 Aug;9(8):679-87
pubmed: 11587642
Nat Rev Immunol. 2006 Jun;6(6):465-75
pubmed: 16724100
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nature. 2006 Mar 23;440(7083):540-4
pubmed: 16525420
J Biol Chem. 1996 Apr 19;271(16):9273-80
pubmed: 8621588
J Immunol. 1994 Oct 1;153(7):2974-82
pubmed: 8089481
Arch Biochem Biophys. 1985 Dec;243(2):605-18
pubmed: 4083905
Clin Immunol. 2002 Feb;102(2):117-34
pubmed: 11846453
PLoS One. 2016 Sep 07;11(9):e0162456
pubmed: 27603942
Infect Immun. 2009 May;77(5):2065-75
pubmed: 19237519
Angew Chem Int Ed Engl. 2014 Aug 25;53(35):9267-70
pubmed: 25044646
Structure. 1994 Nov 15;2(11):1049-59
pubmed: 7881905
Infect Immun. 2007 Jun;75(6):3150-9
pubmed: 17353279
J Immunol. 2004 Dec 1;173(11):6831-40
pubmed: 15557177
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12895-900
pubmed: 25136128
Nat Protoc. 2007;2(12):3278-84
pubmed: 18079728
PLoS One. 2009 Oct 06;4(10):e7215
pubmed: 19806186
Front Microbiol. 2015 Apr 14;6:305
pubmed: 25926825
Nat Rev Immunol. 2003 Dec;3(12):939-51
pubmed: 14647476
Sci Signal. 2019 Mar 05;12(571):
pubmed: 30837305
Nat Cell Biol. 2010 Jan;12(1):11-8; sup pp 1-12
pubmed: 20023649
Blood. 2015 May 21;125(21):3287-96
pubmed: 25784678
Nat Chem Biol. 2005 Jul;1(2):93-7
pubmed: 16408005
Curr Opin Struct Biol. 2005 Oct;15(5):525-34
pubmed: 16140523
Front Immunol. 2018 Sep 19;9:2011
pubmed: 30283436
J Pediatr. 1984 Feb;104(2):206-10
pubmed: 6420530
J Immunol. 2008 Feb 15;180(4):2347-56
pubmed: 18250444
Arch Biochem Biophys. 1980 Apr 15;201(1):160-73
pubmed: 7396494
PLoS One. 2019 Jul 23;14(7):e0219817
pubmed: 31335868
Mol Immunol. 2010 Nov-Dec;48(1-3):351-5
pubmed: 20801511
Infect Control Hosp Epidemiol. 2020 Jul;41(7):777-783
pubmed: 32441235
J Immunol. 2002 Jun 1;168(11):5582-8
pubmed: 12023354
Immunity. 2013 Mar 21;38(3):461-74
pubmed: 23499492
J Biol Chem. 1996 Nov 29;271(48):30487-92
pubmed: 8940015
J Am Soc Mass Spectrom. 2016 Jul;27(7):1143-55
pubmed: 27038031
Pharmaceuticals (Basel). 2021 Feb 28;14(3):
pubmed: 33670993
Structure. 2019 May 7;27(5):764-775.e3
pubmed: 30853410
J Autoimmun. 2015 Feb;57:1-13
pubmed: 25578468
J Biol Chem. 1997 Jun 20;272(25):15613-9
pubmed: 9188449
J Biol Chem. 2012 Feb 3;287(6):4335-47
pubmed: 22170069
Biochim Biophys Acta. 2015 Apr;1853(4):830-40
pubmed: 25450974
J Cyst Fibros. 2004 Aug;3 Suppl 2:95-6
pubmed: 15463936
J Immunol. 1996 Aug 1;157(3):1200-6
pubmed: 8757626
Clin Microbiol Rev. 2010 Apr;23(2):299-323
pubmed: 20375354
J Biol Chem. 2018 Jun 1;293(22):8672-8690
pubmed: 29535184
Curr Opin Immunol. 2010 Jun;22(3):299-307
pubmed: 20434893
J Biol Chem. 1995 Nov 3;270(44):26184-91
pubmed: 7592823
J Exp Med. 2003 May 5;197(9):1125-39
pubmed: 12719481
Glycobiology. 2004 Nov;14(11):53R-62R
pubmed: 15229195
J Leukoc Biol. 2008 Jun;83(6):1370-8
pubmed: 18372337
Nat Commun. 2018 Aug 17;9(1):3288
pubmed: 30120235
J Appl Microbiol. 2008 Jun;104(6):1539-51
pubmed: 18217926
ACS Chem Biol. 2013 Sep 20;8(9):1918-24
pubmed: 23855446
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6302-7
pubmed: 9600960
Blood. 2012 Mar 8;119(10):2293-301
pubmed: 22234695
N Engl J Med. 1968 Aug 15;279(7):361-2
pubmed: 5662168
Mol Cell Proteomics. 2019 Apr;18(4):686-703
pubmed: 30659065
Am J Trop Med Hyg. 2016 Jan;94(1):114-121
pubmed: 26598565

Auteurs

Marco Frensch (M)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Christina Jäger (C)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.

Peter F Müller (PF)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.

Annamaria Tadić (A)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.

Isabel Wilhelm (I)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.

Sarah Wehrum (S)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.

Britta Diedrich (B)

Department of Biology, University of Fribourg, Fribourg, Switzerland.
Department of Dermatology, University Medical Center and University of Freiburg, Freiburg, Germany.

Beate Fischer (B)

Center for Chronic Immunodeficiency, CCI and University Medical Center Freiburg, Freiburg, Germany.

Ana Valeria Meléndez (AV)

Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany.

Joern Dengjel (J)

Department of Biology, University of Fribourg, Fribourg, Switzerland.
Department of Dermatology, University Medical Center and University of Freiburg, Freiburg, Germany.

Hermann Eibel (H)

Center for Chronic Immunodeficiency, CCI and University Medical Center Freiburg, Freiburg, Germany. hermann.eibel@uniklinik-freiburg.de.

Winfried Römer (W)

Faculty of Biology, University of Freiburg, Freiburg, Germany. winfried.roemer@bioss.uni-freiburg.de.
Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. winfried.roemer@bioss.uni-freiburg.de.
International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. winfried.roemer@bioss.uni-freiburg.de.
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany. winfried.roemer@bioss.uni-freiburg.de.
Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany. winfried.roemer@bioss.uni-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH